SCHEMBL7140644

SCHEMBL7140644

[CH2]c1cccc(NC(N)=O)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.50
GAA P10253 1/20 0.50
GFER P55789 1/20 0.50
DDX3X O00571 1/20 0.46
PEPD P12955 1/20 0.45
KIF11 P52732 2/20 0.45
ALDH1A1 P00352 4/20 0.44
NPC1 O15118 1/20 0.44
GPR35 Q9HC97 1/20 0.44
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
KCNK3 O14649 1/20 0.41
KCNK9 Q9NPC2 1/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
HTR3E A5X5Y0 1/20 0.41
HTR3B O95264 1/20 0.41
HTR3A P46098 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3690365 0.85 MAPT (0.59) MAPTGAAGFERDDX3XPEPD
SCHEMBL28332617 0.82 GPR35 (0.50) MAPTGAADDX3XALDH1A1NPC1
SCHEMBL7391700 0.80 KMT2A (0.40) DDX3XALDH1A1GPR35KMT2AMEN1
SCHEMBL839236 0.80 ALDH1A1 (0.63) MAPTALDH1A1NPC1KMT2AMEN1
SCHEMBL1356066 0.79 CA1 (0.59) MAPTGAACA1CA2KMT2A
SCHEMBL8698243 0.79 PEPD (0.46) MAPTGAAGFERPEPDKIF11
SCHEMBL5544315 0.78 MAPT (0.52) MAPTGAAGFERDDX3XPEPD
SCHEMBL3185695 0.78 KMT2A (0.66) MAPTGAAGFERPEPDALDH1A1
SCHEMBL33716 0.78 DDX3X (0.74) MAPTGAAGFERDDX3XPEPD
SCHEMBL7564141 0.78 GAA (0.52) MAPTGAAGFERDDX3XPEPD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1189929-B1 FACTOR VIIA INHIBITORS AVENTIS PHARMA GMBH (DE) 2003-08-06 EP disclosed
US-6500803-B1 Factor VIIa inhibitors AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2002-12-31 US disclosed
EP-1189929-A2 FACTOR VIIA INHIBITORS Aventis Pharma Deutschland GmbH (DE) 2002-03-27 EP disclosed
WO-2000075172-A2 FACTOR VIIa INHIBITORS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-12-14 WO disclosed
EP-1059302-A1 Factor VIIa inhibitors Aventis Pharma Deutschland GmbH (DE) 2000-12-13 EP disclosed
US-5614498-A OLIGOPEPTIDES, BRONCHDILATORS BANYU PHARMACEUTICAL CO., LTD. (JP) 1997-03-25 US disclosed
US-5496928-A Endothelin antagonistic substance BANYU PHARMACEUTICAL CO., LTD. (JP) 1996-03-05 US disclosed
EP-0555537-A2 Endothelin antagonistic substance BANYU PHARMACEUTICAL CO., LTD. (JP) 1993-08-18 EP disclosed
EP-0329169-A1 N-(lower alkyl)-2-(3'-ureidobenzyl)-pyrrolidines SYNTEX (U.S.A.) INC. (US) 1989-08-23 EP disclosed
US-4826869-A GLAUCOMA SYNTEX (U.S.A.) INC. (US) 1989-05-02 US disclosed